Home NDC 75834-124
Acyclovir
Product NDC 75834-124
11-digit product format 758340124
Labeler code 75834
Product ID 75834-124_bdd7c1ab-7f2d-43b5-9ff7-238aa1b9576f
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Acyclovir
Dosage form CAPSULE
Route ORAL
Labeler Nivagen Pharmaceuticals, Inc.
Application ANDA201445
Marketing category ANDA
Marketing start 2016-10-15
Substance ACYCLOVIR
Active strength 200 mg/1
Pharmacologic classes DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]
NDC exclude flag No
Listing certified through 2026-12-31
Current FDA listing Yes Additional Listing Data#
Finished product Yes
Brand name base Acyclovir
Listing expiration 2026-12-31
Active Ingredients# Ingredient, Strength table Ingredient Strength ACYCLOVIR 200 mg/1
Harmonized Identifiers# Field, Values table Field Values Unii X4HES1O11F Rxcui 197310
DailyMed Product Concepts# FDA-Initiated Inactive NDC Indexing# NDC, Effective, Action table NDC Effective Action Document Indexing SPL Related label 75834-124-01 2022-02-15 C162847 48780-1 9d75b9d1-1911-f424-e053-dadaa90a57ce Acyclovir Capsules, USP 200 mg Nivagen Pharmaceuticals, Inc. 75834-124-05 2022-02-15 C162847 48780-1 9d75b9d1-1911-f424-e053-dadaa90a57ce Acyclovir Capsules, USP 200 mg Nivagen Pharmaceuticals, Inc. 75834-124-01 2022-01-28 C162847 48780-1 9d75b9d1-1911-f424-e053-dadaa90a57ce Acyclovir Capsules, USP 200 mg Nivagen Pharmaceuticals, Inc. 75834-124-05 2022-01-28 C162847 48780-1 9d75b9d1-1911-f424-e053-dadaa90a57ce Acyclovir Capsules, USP 200 mg Nivagen Pharmaceuticals, Inc. 75834-124-01 2020-05-05 C162847 48780-1 9d75b9d1-1911-f424-e053-dadaa90a57ce Acyclovir Capsules, USP 200 mg Nivagen Pharmaceuticals, Inc. 75834-124-05 2020-05-05 C162847 48780-1 9d75b9d1-1911-f424-e053-dadaa90a57ce Acyclovir Capsules, USP 200 mg Nivagen Pharmaceuticals, Inc. 75834-124-01 2020-01-31 C162847 48780-1 9d75b9d1-1911-f424-e053-dadaa90a57ce Acyclovir Capsules, USP 200 mg Nivagen Pharmaceuticals, Inc. 75834-124-05 2020-01-31 C162847 48780-1 9d75b9d1-1911-f424-e053-dadaa90a57ce Acyclovir Capsules, USP 200 mg Nivagen Pharmaceuticals, Inc.
DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 75834-124-01 Acyclovir 100 in 1 BOTTLE CAPSULE 100 4 75834-124-05 Acyclovir 500 in 1 BOTTLE CAPSULE 500 4
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 75834-124 ACYCLOVIR CAPSULE [NIVAGEN PHARMACEUTICALS, INC.] 4 Current NDC, Legacy NDC, 2 package rows 20220216_1b0919aa-0d41-4c91-9ef4-049ac9e27d78.zip
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 75834-124-01 75834012401 100 CAPSULE in 1 BOTTLE (75834-124-01) 100 capsule 2016-10-15 0000-00-00 No No Current 75834-124-05 75834012405 500 CAPSULE in 1 BOTTLE (75834-124-05) 500 capsule 2016-10-15 0000-00-00 No No Current